Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Myrexis, Inc.

Myrexis is a biopharmaceutical company based in Salt Lake City, Utah, USA. It focuses on drug development in several areas of medicine, in particular cancer therapy. It was founded in 1999 as a spin-off from Myriad Genetics and was originally known as Myriad Pharmaceuticals. Richard B. Brewer was its CEO from May 2012 until his death in August 2012.

Investment goal date:
Dividends reinvested
Myrexis, Inc. MYRX report Q4 2014
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2014
2014-07-17
0.0000
0.0000
Q3 2014
2014-04-17
0.0000
0.0000
Q2 2014
2014-01-17
0.0000
0.0000
Q1 2014
2013-10-17
0.0000
0.0000
Q4 2013
2013-07-17
0.0000
0.0000
Q3 2013
2013-05-10
0.0000
-0.1100
Q2 2013
2013-02-08
0.0000
-0.1800
Q1 2013
2012-11-09
0.0000
-0.1300
Q4 2012
2012-09-13
0.0000
-0.1600
Q3 2012
2012-05-10
0.0000
-0.4000
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Major Shareholders
Name Relationship
Total Shares
Holding stocks
LOLLINI ROBERT J
0.1300% (44690)
MYRX /
HOBDEN ADRIAN N
0.6000% (208372)
MYRX /
HENDERSON JOHN T
0.1000% (33500)
CYTK / MYGN / MYRX /
Laslie W Wayne
0.1700% (57254)
MYRX /
First Eagle Investment Management, LLC
7.7500% (2671617)
ARDM / IVAC / MYRX /
Aryeh Jason
1.5800% (545245)
Belle Gerald P.
0.2200% (77230)
MYRX / PDII /
Gibbs Andrew
0.0600% (19847)
MYRX /
Berry Barbara
0.0500% (17284)
MYRX /
Swabb Edward
0.0400% (15000)
MYRX /
% ()